Your browser doesn't support javascript.
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases.
Connolly, Caoilfhionn M; Ruddy, Jake A; Boyarsky, Brian J; Avery, Robin K; Werbel, William A; Segev, Dorry L; Garonzik-Wang, Jacqueline; Paik, Julie J.
  • Connolly CM; Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA connolly@jhmi.edu.
  • Ruddy JA; Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Boyarsky BJ; Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Avery RK; Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA.
  • Werbel WA; Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA.
  • Segev DL; Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Garonzik-Wang J; Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Paik JJ; Surgery, Johns Hopkins, Baltimore, Maryland, USA.
Ann Rheum Dis ; 80(8): 1100-1101, 2021 08.
Article in English | MEDLINE | ID: covidwho-1145359
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatic Diseases / Musculoskeletal Diseases / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220231

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatic Diseases / Musculoskeletal Diseases / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2021-220231